Don Jr. leads suspicion over the timing of Pfizer’s COVID-19 ‘breakthrough’ that came two days …

Along with Pfizer’s own share price, airline stocks skyrocketed on Monday after the announcement as people finally saw a ‘light at the end of the tunnel’.

Donald Trump Jr. has cast suspicion over the timing of Pfizer’s COVID-19 vaccine ‘breakthrough’ which was announced on Monday two days after the election was called for Biden.

Pfizer revealed on Monday that its vaccine was 90 percent effective among study participants and that it would produce 1.3billion doses – enough to treat 650million people – by the end of the next year.

The breakthrough was unexpected given the company’s CEO’s previous remarks that it would be towards the end of the month before they had significant data to submit to the FDA for emergency authorization.

In September, Pfizer CEO Albert Bourla promised that they would know whether or not the vaccine was effective by the end of October, a deadline that fit with Trump’s promise to find a vaccine that worked before the November 3 election.

But that deadline came and went with no news. America went to the polls on November 3. Many told pollsters that the handling of the crisis was one of the most important issues on their minds.

Then suddenly on Monday, after the entire country waited four days for an election result, Pfizer announced their breakthrough, touting it as a ‘great day for humanity’ and science.

Efficacy is one of three components he said the company had to consider when submitting it for FDA approval. The other two are safety and whether or not it can be mass-produced to the right standards.

While Monday’s announcement does not technically speed up the process of the vaccine being rolled out to the masses (Pfizer still says it needs until the end of November to collate all the data to ask for authorization), it drums up huge global excitement and has given some industries a huge boost in the markets.

Donald Trump Jr. raised suspicion on Monday after Pfizer announced its vaccine was 90% effective, two days after the election went to Joe Biden, after previously delaying the results

Donald Trump Jr. raised suspicion on Monday after Pfizer announced its vaccine was 90% effective, two days after the election went to Joe Biden, after previously delaying the results

Along with Pfizer’s own share price, airline stocks skyrocketed on Monday after the announcement as people finally saw a ‘light at the end of the tunnel’.

PFIZER VACCINE TIMELINE

SEPTEMBER 13: Pfizer CEO Anthony Bourla says they will know if the vaccine is effective by the end of October

OCTOBER 16: In an open letter, Bourla promises again to know if the vaccine is effective by the end of October

He said the company wouldn’t know if all three components – efficacy, safety and manufacturing – were up to par until the third week of November

OCTOBER 30-NOVEMBER 8: No update on efficacy of the vaccine

NOVEMBER 3: Presidential election

NOVEMBER 7: The election is called for Joe Biden

NOVEMBER 9: Pfizer announces results of efficacy study, says they expanded perimeters of it after consulting the FDA but doesn’t say when or why

Advertisement

It also came at the same time as Biden started unveiling his COVID-19 task force.

Donald Trump Jr. tweeted sarcastically: ‘The timing of this is pretty amazing. Nothing nefarious about the timing of this at all right?’

Data on how effective it was – the clearest sign of whether or not it works – had been expected by the end of October.

The end of October came and went with no news how effective it was.

In its announcement Monday, Pfizer said the results of the interim analysis came after a discussion with the FDA. It is not yet clear exactly what those discussions involved or when they occurred.

The company only said that, based on those discussions, they had opted to conduct the interim analysis based on a minimum of 62 cases instead of an initial 32 case figure. The cases relate to the number of the 44,000 people involved in the trial that have contracted COVID-19. The 90 percent rate ended up being based on 94 cases.

Then on Monday, Pfizer announced they said they had just received the results of their first interim efficacy analysis from an external Data Monitoring Committee on Sunday.

President-elect Biden said he found out about it on Sunday night from his ‘public health advisors’.

He is not due to take office until January 20.

‘Last night, my public health advisors were informed of this excellent news.

‘I congratulate the brilliant women and men who helped produce this breakthrough and to give us such cause for hope,’ he said.

Biden went on to say that while it was good news, the fight against COVID was far from over.

Trump himself resisted questioning the timing of the announcement and instead tweeted his excitement over it.

He tweeted: ‘STOCK MARKET UP BIG, VACCINE COMING SOON. REPORT 90% EFFECTIVE. SUCH GREAT NEWS!’

Within a few hours of the news, Democrats started politicizing the development and saying even though the vaccine may work, it won’t be rolled out properly under Trump’s administration.

New York Governor Andrew Cuomo went on Good Morning America to say that he and other governors were going to try to stop Trump’s roll-out plan.

‘It’s good news, bad news. The bad news is it’s about two months before Joe Biden takes over and it means this administration is going to be implementing a vaccine plan.

SEPTEMBER 13: Pfizer's Greek CEO, Albert Bourla, said they would know if the vaccine would be effective by the end of October

SEPTEMBER 13: Pfizer’s Greek CEO, Albert Bourla, said they would know if the vaccine would be effective by the end of October

Pfizer did not announce the efficacy of its vaccine until Monday morning

Pfizer did not announce the efficacy of its vaccine until Monday morning

Joe Biden said on Monday that he was informed about the vaccine efficacy on Sunday night

Joe Biden said on Monday that he was informed about the vaccine efficacy on Sunday night

Trump resisted questioning the timing of the announcement on Monday and instead focused on the boost it gave the markets

Trump resisted questioning the timing of the announcement on Monday and instead focused on the boost it gave the markets

Democrats are already trying to block the Trump campaign from rolling the vaccine out. On Monday morning, NY Gov Andrew Cuomo said he and other governors want to stop their plan before they do 'damage' by implementing it through private practices

Democrats are already trying to block the Trump campaign from rolling the vaccine out. On Monday morning, NY Gov Andrew Cuomo said he and other governors want to stop their plan before they do ‘damage’ by implementing it through private practices

PFIZER’S GREEK CEO WHO WAS ‘DISAPPOINTED’ IN TRUMP AFTER DEBATE AND WHO DONATED TO MITCH MCCONNELL AND THE REPS – BUT NOT THE PRESIDENT

Pfizer CEO Albert Bourla

Pfizer CEO Albert Bourla

Albert Bourla’s affiliations are not as clear cut as some business leaders but his disdain for Trump is apparent.

He donated to Republican campaigns this year, including to Mitch McConnell’s and the Republican party in Kentucky, but he did not donate to the Trump campaign .

He gave $60,783 to committees associated with McConnell and Republican Senators John Cornyn, Cory Gardner, and Thom Tillis.

Bourla’s compensation last year was $17.9million.

He has worked for Pfizer since 1993, first in his native Greece then in New York and took over as CEO last year.

He is intensively private, sharing nothing of his family life publicly.

He has refrained from speaking about Trump beyond saying that he was ‘disappointed’ when the President said Pfizer could go faster when developing a vaccine.

It was during the presidential debate that Trump made the remark.

‘I’ve spoken to Pfizer, I’ve spoken to all of the people that you have to speak to, Moderna, Johnson & Johnson, and others. They can go faster than that by a lot. It’s become very political. We’re weeks away from a vaccine,’ Trump said.

Bourla responded by saying he was going at the pace ‘of science’.

‘Tuesday night I joined the millions of Americans who tuned in to the Presidential debate.

‘Once more, I was disappointed that the prevention for a deadly disease was discussed in political terms rather than scientific facts. The only pressure we feel — and it weighs heavy — are the billions of people, millions of businesses and hundreds of government officials that are depending on us.’

Bourla is also a member of Catalyst, a non-profit dedicated to boosting opportunities for women in the workplace, and he sits on the board of big business and big pharma organizations – both of which Trump has made enemies of.

Advertisement

‘It’s very important. The Trump administration is rolling out the plan and I believe it’s flawed.

‘When you deny a problem the way Trump did, you can never solve it. They’re going to go through the private mechanism – through drug market chains.

‘You have two months and we can’t let this vaccination plan go forward the way the Trump administration is planning it. I’ve been talking to Governors across the nation about that.

‘How can we shape the Trump administration vaccine plan to fix it or stop it before it does damage?’

Senator Ted Cruz said Cuomo’s remarks were ‘revealing’.

Trump’s handling of the pandemic was one of the Democrats’ main talking points throughout the campaign.

They slammed his failure to implement things like a nationwide mask mandate, and President-elect Joe Biden has already announced his own task force to reverse some of Trump’s decisions.

This year, Pfizer CEO Albert Bourla donated to Republican campaigns including Mitch McConnell’s and the Republican party in Kentucky, but he did not donate to the Trump campaign .

He has refrained from speaking about Trump beyond saying that he was ‘disappointed’ when the President said Pfizer could go faster when developing a vaccine.

It was during the presidential debate that Trump made the remark.

‘I’ve spoken to Pfizer, I’ve spoken to all of the people that you have to speak to, Moderna, Johnson & Johnson, and others. They can go faster than that by a lot. It’s become very political. We’re weeks away from a vaccine,’ Trump said.

Bourla responded by saying he was going at the pace ‘of science’.

‘Tuesday night I joined the millions of Americans who tuned in to the Presidential debate.

‘Once more, I was disappointed that the prevention for a deadly disease was discussed in political terms rather than scientific facts. The only pressure we feel — and it weighs heavy — are the billions of people, millions of businesses and hundreds of government officials that are depending on us.’

Bourla is also a member of Catalyst, a non-profit dedicated to boosting opportunities for women in the workplace, and he sits on the board of big business and big pharma organizations – both of which Trump has made enemies of.